|
INTS12 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.0176083026513E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.1961100432909E-12 |
| Normal-vs-Stage2 |
4.90249951745625E-10 |
| Normal-vs-Stage3 |
4.42180003723536E-09 |
| Normal-vs-Stage4 |
6.06740000463901E-08 |
| Stage1-vs-Stage2 |
6.616000E-01 |
| Stage1-vs-Stage3 |
3.104600E-01 |
| Stage1-vs-Stage4 |
4.342400E-01 |
| Stage2-vs-Stage3 |
4.839200E-01 |
| Stage2-vs-Stage4 |
4.097800E-01 |
| Stage3-vs-Stage4 |
9.000200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.19371179607697E-12 |
| Normal-vs-AfricanAmerican |
1.31938904246454E-12 |
| Normal-vs-Asian |
7.58360000000513E-05 |
| Caucasian-vs-AfricanAmerican |
3.482600E-01 |
| Caucasian-vs-Asian |
7.434200E-01 |
| AfricanAmerican-vs-Asian |
9.961200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.68565161828838E-12 |
| Normal-vs-Female |
6.89610002435614E-09 |
| Male-vs-Female |
4.709500E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.58289953261703E-10 |
| Normal-vs-Extreme_Weight |
2.41010544854703E-11 |
| Normal-vs-Obese |
9.58244594784219E-12 |
| Normal-vs-Extreme_Obese |
2.27789999995842E-06 |
| Normal_Weight-vs-Extreme_Weight |
5.357000E-01 |
| Normal_Weight-vs-Obese |
7.138600E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.192000E-01 |
| Extreme_Weight-vs-Obese |
7.636000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.969000E-01 |
| Obese-vs-Extreme_Obese |
9.816600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.87010000041177E-07 |
| Normal-vs-Age(41-60Yrs) |
3.66290331399455E-11 |
| Normal-vs-Age(61-80Yrs) |
2.29816166097407E-14 |
| Normal-vs-Age(81-100Yrs) |
2.181200E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.632400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.852400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.206000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.185900E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.054000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.959800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.52855506030392E-12 |
| Normal-VS-Type2 PRCC |
1.74749104076E-13 |
| Normal-VS-KIRP CIMP |
1.43070000291345E-09 |
| Normal-VS-Unclassified PRCC |
3.0710999999739E-06 |
| Type1 PRCC-VS-Type2 PRCC |
1.683000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
7.712200E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
3.256800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.311800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
6.089700E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
2.804200E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.12063699933651E-12 |
| Normal-vs-N1 |
2.3934000337178E-09 |
| Normal-vs-N2 |
1.68922999999044E-05 |
| N0-vs-N1 |
9.785200E-01 |
| N0-vs-N2 |
5.012800E-01 |
| N1-vs-N2 |
5.182800E-01 |
|
|
